Parkinson's disease, Ozempic
Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds
WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's disease have taken an hit. A new study found that a drug in the same class called exenatide, marketed as Byetta, had no effect on slowing the disease or easing its symtoms.
Hosted on MSN1h
7MM parkinson’s disease market to hit $7.9b by 2033The number of diagnosed cases is expected to rise to 3.1 million. The Parkinson’s disease (PD) market across the seven major ...
Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...
The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...
Marc Cohn is sharing his Parkinson’s disease diagnosis publicly for the first time. The “Walking in Memphis” artist, 65, took to Instagram on Thursday, Jan. 30 to share a health update with his fans ...
All aboard the "Crazy Train" — Black Sabbath will be reuniting for a performance in Ozzy Osbourne's hometown of Birmingham, U ...
The FDA on Tuesday signed off on Supernus Pharmaceuticals’ apomorphine hydrochloride injection—to be marketed under the brand ...
Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...
The singer-songwriter gained recognition from the Recording Academy in the early 1990s, winning the Grammy for Best New ...
Doctors and researchers say ping pong can help slow Parkinson's disease. The South County Recreation Center in Bixby hosts ...
Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback